$232.640
-1.140 (-0.49%)收盘时
STE 资讯
STE 事件
Steris Invests $600M to Build Manufacturing Center in North Carolina
Steris announced that it will be investing $600M to build a formulated chemistries manufacturing and distribution Center of Excellence in North Carolina, near the Raleigh-Durham Research Triangle region. The facility will serve as a central hub to produce high-performance infection prevention and contamination control chemistries used across the Healthcare and Pharmaceutical industries.
Steris Announces Quarterly Dividend of 69 Cents per Share
Steris announced that the company will distribute a quarterly interim dividend of 69c per share. This represents a 6c increase in the dividend. The dividend is payable on September 25 to shareholders of record at the close of business on September 4.
Sees FY27 Revenue Growth 7%-8% from $5.9B
Sees FY27 revenue growth 7%-8% from $5.9B, consensus $6.31B. Sees FY27 CapEx $375M.
Company Reports Q4 Revenue of $1.6B
Reports Q4 revenue $1.6B, consensus $1.6B. "FY26 was another record year," said CEO Dan Carestio. "Our diversified Customer base and growth in procedure volumes continue to drive our performance. We appreciate the efforts of our global Associates who continue to put our Customers first. As we look ahead, we are excited for what is to come as we capitalize on our unique ability to help our Customers enable procedural growth, deliver quality outcomes and drive compliance with standardization and optimization."
STERIS Q3 Revenue of $1.5B Beats Expectations
Reports Q3 revenue $1.5B, consensus $1.48B. "We are pleased with our performance in the third quarter," said Dan Carestio, President and CEO of STERIS. "Our performance continues to benefit from strong execution by our commercial teams and our diversified portfolio. High single digit revenue growth combined with cost discipline is allowing us to deliver meaningful earnings per share growth despite increased tariff headwinds."
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。